Pin1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

215 results for “Pin1”

Trials

View all 165 →

Active, not recruiting

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

9,000 participants · First posted Jun 20, 2024

Comparison of Cross Pin Configurations in Supracondylar Humerus Fracture Treatment: 2 Pins Versus 3 Pins

45 participants · First posted Oct 9, 2020

Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old

90 participants · First posted Aug 26, 2022

Drugs

View all 29 →

PIN1(Larkspur Biosciences)

Pin1 inhibitors(Ohio State University)

Pin1 inhibitors(The Ohio State University)

Organizations

PINK PEARLS INC

United States

Beijing PINS Medical Co., Ltd.

China

PINE REST CHRISTIAN MENTAL HEALTH SERVICES

United States

News

View all 16 →

Pin1 Inhibitors Demonstrate Novel Antiviral Mechanism Against HSV-1 by Trapping Virus in Cell Nucleus

The Cancer–Alzheimer's Paradox: Unraveling the Inverse Relationship Between Two Age-Related Diseases

Pin Therapeutics Begins First-in-Human Trial of CK1α Degrader PIN-5018 for Rare Adenoid Cystic Carcinoma

Page 1 of 22